| In millions, except per share items | Dec-31-15 | Dec-31-14 | Dec-31-13 | Dec-31-12 | Dec-31-11 | Dec-31-10 | Dec-31-09 | Dec-31-08 |
| | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K |
| Revenues: |
| United States | 345.3 | 333.1 | 316.2 | 313.2 | 311.9 | 262.2 | 239.4 | 153.6 |
| Intellectual Property Licensing | 281.8 | 285.2 | 293.2 | 275.5 | | | | |
| Product Operating Segment | 244.4 | 257.2 | 244.2 | 250.6 | | | | |
| International | | | | 212.9 | 272.2 | 279.3 | 241.1 | 173.9 |
| Total revenues [+] | 526.3 | 542.3 | 537.4 | 526.1 | 584.1 | 541.5 | 480.5 | 327.4 |
| Royalties | 100.6 | 107.1 | 111.3 | 118.0 | | | | |
| Revenue growth [+] | -3.0% | 0.9% | 2.1% | -9.9% | 7.9% | 12.7% | 46.7% | 125.9% |
| United States | 3.7% | 5.3% | 0.9% | 0.4% | 18.9% | 9.5% | 55.9% | 141.0% |
| Intellectual Property Licensing | -1.2% | -2.7% | 6.4% | | | | | |
| Product Operating Segment | -4.9% | 5.3% | -2.6% | | | | | |
| International | | | | -21.8% | -2.5% | 15.8% | 38.6% | 114.1% |
| Cost of goods sold | 100.6 | 104.4 | 95.6 | 105.1 | 88.0 | 99.1 | 65.3 | 44.3 |
| Gross profit | 425.6 | 437.9 | 441.8 | 421.0 | 496.1 | 442.4 | 415.2 | 283.1 |
| Gross margin | 80.9% | 80.7% | 82.2% | 80.0% | 84.9% | 81.7% | 86.4% | 86.5% |
| Selling, general and administrative | 154.4 | 138.4 | 147.5 | 139.5 | 160.7 | 142.2 | 132.9 | 114.6 |
| Research and development | 100.6 | 107.1 | 111.3 | 118.0 | 122.0 | 95.7 | 92.0 | 65.9 |
| EBITDA [+] | 170.6 | 192.4 | 182.9 | 163.5 | 213.4 | 204.5 | 190.3 | 102.7 |
| EBITDA growth | -11.4% | 5.2% | 11.9% | -23.4% | 4.4% | 7.5% | 85.3% | 52.8% |
| EBITDA margin | 32.4% | 35.5% | 34.0% | 31.1% | 36.5% | 37.8% | 39.6% | 31.4% |
| Depreciation | 17.4 | 17.5 | 16.8 | 20.0 | 18.8 | 18.8 | 18.4 | 13.8 |
| EBITA | 153.2 | 174.9 | 166.1 | 143.5 | 194.6 | 185.7 | 171.9 | 88.9 |
| EBITA margin | 29.1% | 32.2% | 30.9% | 27.3% | 33.3% | 34.3% | 35.8% | 27.1% |
| Amortization of intangibles | 77.0 | 77.9 | 74.4 | 74.3 | 77.1 | 80.4 | 81.9 | 59.1 |
| EBIT [+] | 76.2 | 97.0 | 91.7 | 69.2 | 117.5 | 105.3 | 90.0 | 29.7 |
| EBIT growth | -21.5% | 5.8% | 32.6% | -41.1% | 11.5% | 17.1% | 202.7% | -47.0% |
| EBIT margin | 14.5% | 17.9% | 17.1% | 13.1% | 20.1% | 19.5% | 18.7% | 9.1% |
| Non-recurring items [+] | 4.4 | 13.3 | 8.4 | 4.7 | 20.5 | | 53.6 | |
| Asset impairment | 2.2 | 10.9 | 7.6 | 4.7 | 20.5 | | 53.6 | |
| Loss (gain) on sale of assets | -0.1 | -0.5 | | | | | | |
| Interest expense, net [+] | 46.1 | 50.7 | 59.2 | 58.5 | 48.9 | 41.2 | 47.5 | 43.6 |
| Interest expense | 46.8 | 54.8 | 62.0 | 61.7 | 53.8 | 42.9 | 52.0 | 54.8 |
| Interest income | 0.7 | 4.1 | 2.8 | 3.2 | 4.9 | 1.8 | 4.6 | 11.2 |
| Other income (expense), net [+] | -16.2 | -26.8 | -1.2 | -16.9 | -15.8 | 23.3 | -8.7 | 5.2 |
| Gain (loss) on investments | | | | | | 5.9 | | 5.2 |
| Gain (loss) on debt retirement | -2.8 | -5.2 | -2.8 | -1.8 | -11.5 | -0.3 | -3.1 | |
| Gain (loss) on derivative instruments | -13.4 | -17.9 | 2.9 | -10.6 | -4.3 | 34.2 | | |
| Pre-tax income | 9.5 | 6.2 | 22.9 | -11.0 | 32.3 | 87.4 | -19.8 | -8.6 |
| Income taxes | 13.8 | 19.7 | 1.5 | 9.2 | 24.3 | -139.2 | -1.4 | -23.4 |
| Tax rate | 145.4% | 318.0% | 6.7% | | 75.2% | | 7.2% | 271.3% |
| Net income | -4.3 | -69.7 | -172.1 | -34.3 | -41.3 | 212.9 | -53.0 | -114.1 |
| Net margin | -0.8% | -12.9% | -32.0% | -6.5% | -7.1% | 39.3% | -11.0% | -34.8% |
| |
| Basic EPS [+] | ($0.05) | ($0.15) | $0.22 | ($0.19) | $0.07 | $2.21 | ($0.18) | $0.17 |
| Growth | -65.4% | -168.0% | -212.7% | -361.5% | -96.7% | -1311.1% | -205.3% | -77.2% |
| Diluted EPS [+] | ($0.05) | ($0.15) | $0.22 | ($0.19) | $0.07 | $2.08 | ($0.18) | $0.17 |
| Growth | -65.4% | -168.5% | -211.8% | -371.6% | -96.6% | -1238.8% | -205.3% | -76.9% |
| |
| Shares outstanding (basic) [+] | 84.1 | 91.7 | 98.4 | 104.6 | 108.9 | 102.7 | 100.9 | 85.3 |
| Growth | -8.2% | -6.8% | -6.0% | -3.9% | 6.1% | 1.8% | 18.2% | 62.6% |
| Shares outstanding (diluted) [+] | 84.1 | 91.7 | 99.1 | 104.6 | 113.1 | 109.2 | 100.9 | 85.4 |
| Growth | -8.2% | -7.5% | -5.3% | -7.5% | 3.6% | 8.2% | 18.2% | 60.7% |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |